Pulmonary Fibrosis, Idiopathic

- Cell Therapy Approaches

Idiopathic pulmonary fibrosis (IPF) is a progressive form of interstitial lung disease. In IPF, lung tissue becomes scarred, resulting in breathing difficulties. While the lung damage caused by pulmonary fibrosis is irreparable, palliative therapies can ease symptoms and improve quality of life.

Cell Therapy Approaches

Restoration of the alveolar epithelium is a desirable therapeutic endpoint of IPF. In the injured lungs, production of inflammatory signaling molecules recruit stem/progenitor cells to the site of injury to restore the integrity of the epithelial layer. Stem cells can differentiate into lung epithelial and endothelial cells, ameliorating lung injury and fibrosis. Both structural engraftment and/or paracrine/immunomodulatory effects produced by stem cell therapy may be responsible for therapeutic benefits in IPF.

This site does not provide medical advice and is for research use only

Welcome to
LifeMap Discovery

Watch the introductory video to learn more about our database of embryonic development for stem cell research and regenerative medicine

Pulmonary Fibrosis, Idiopathic

- Cell Therapy Approaches

Cell Therapy Approaches

Cell Therapies for the treatment of

Modeling of

Affected or Therapy-targeted Cells/Compartments for

Literature related to

Welcome to LifeMap Discovery

Watch the introductory video to learn more about our database of embryonic development for stem cell research and regenerative medicine

Pulmonary Fibrosis, Idiopathic - Cell Therapy Approaches

Cell Therapy Approaches

Cell Therapies for the treatment of

Modeling of

Affected or Therapy-targeted Cells/Compartments for

Literature related to

Welcome to
LifeMap Discovery

Pulmonary Fibrosis, Idiopathic

- Cell Therapy Approaches